Pathological complete response in MMR-deficient/MSI-high and KRAS-mutant patient with locally advanced rectal cancer after neoadjuvant chemoradiation with immunotherapy: A case report.

Front Oncol · 2022 · PMC9545900 · PMID 36212424

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a significant trendno p-value reported

There will be a significant trend for decision-making of neoadjuvant treatment in LARC stratified by mismatch repair or microsatellite instability and KRAS status.

also in 9,775 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.